0001209191-22-029923.txt : 20220518 0001209191-22-029923.hdr.sgml : 20220518 20220518110405 ACCESSION NUMBER: 0001209191-22-029923 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220517 FILED AS OF DATE: 20220518 DATE AS OF CHANGE: 20220518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andriole Michael T. CENTRAL INDEX KEY: 0001698751 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35867 FILM NUMBER: 22937543 MAIL ADDRESS: STREET 1: C/O ENDOCYTE, INC. STREET 2: 3000 KENT AVENUE, SUITE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-17 0 0001117480 CHIMERIX INC CMRX 0001698751 Andriole Michael T. 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 0 1 0 0 Chief Business Officer and CFO Common Stock 2022-05-17 4 P 0 15000 1.709 A 212724 D The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.705 to $1.71, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Includes: i) 13,273 shares acquired under the Issuer's Employee Stock Purchase Plan ("ESPP") on September 10, 2020; ii) 17,361 shares acquired under the Issuer's ESPP on March 10, 2021; and iii) 17,361 shares acquired under the Issuer's ESPP on March 10, 2022. /s/ Michael Alrutz, Attorney-In-Fact 2022-05-18